Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
BW Businessworld

UK Regulator Clears Updated Moderna Vaccine For Omicron Variant

While vaccines have been able to lower hospitalisations and deaths from Covid, which first originated in China in late 2019, the present jabs mainly target the earlier strains of the virus

Photo Credit :

1590656789_F6aDSZ_2020_05_28T071634Z_1_LYNXMPEG4R0JH_RTROPTP_4_HEALTH_CORONAVIRUS_MODERNA_1_.JPG

The UK's drug regulator announced on Monday that it had cleared an updated Moderna vaccine against the Covid 19 virus that specially targets Omicron variant as well as the original form.The MHRA (Medicine and Healthcare products Regulatory Agency) informed in a press statement that it had cleared the vaccine as a booster for adults "after it was found to meet the UK regulator's standards of safety, quality and effectiveness".

It being the first such "bivalent" Covid-19 vaccine to be approved by the British regulator.

The MHRA's chief executive June Raine conveyed that data in the clinical trial showed a "strong immune response" against the original virus and Omicron, and would give a "sharpened tool in our armoury" as the virus kept evolving.

While vaccines have been able to lower hospitalisations and deaths from Covid, which first originated in China in late 2019, the present jabs mainly target the earlier strains of the virus.

The WHO (World Health Organization) warned recently in July that the pandemic is "nowhere near over", due to the spread of Omicron sub-variants and because of the lifting of Covid measures.

Half of the Moderna vaccine, called Spikevax bivalent Original/Omicron, targets the original 2020 virus and half the Omicron variant (BA.1).

The UK regulator stated that the vaccine was also found to generate a "good response" against the two prevalent Omicron subvariants, BA.4 and BA.5, which partly drove waves of new cases in Europe and the United States.

The regulator also said the vaccine had the same "typically mild" side effects as the original Moderna jab.


Tags assigned to this article:
mhra Approval Moderna vaccine